COVID-19 guía clínica y de manejo: actualización

  • Diego Herrera Saludesa Ecuador
  • David Gaus Andean health and development
Palabras clave: Covid-19, actualización julio 2021, guía clínica


Se realiza una actualización del conocimiento medico científico sobre el COVID-19 en relación, a la epidemiologia, factores de riesgo y comorbilidades, fisiopatología, utilidad de los exámenes de imagen, tratamiento, y vacunas


La descarga de datos todavía no está disponible.


1. WHO. Covid-19 Weekly Epidemiological Update.22 June 2021. 45. file:///Users/Downloads/20210622_Weekly_Epi_Update_45.pdf accessed 28 June 2021
2. accessed 28 June 2021
3. accessed 28 june 2021
4. accessed 28 june 2021
5. accessed 28 june 28
6. accessed 28 june 2021
7. Otto S, Day T, Arino J, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology (2021), doi: j.cub.2021.06.049.
8. Abu-Raddad, L.J., Chemaitelly, H., Butt, A.A., and the National Study Group for COVID-19 Vaccination. (2021). Effectiveness of the BNT162b2 COVID-19 vaccine against the B.1.1.7 and B.1.351 variants. New Engl. J. Med. NEJMc2104974.
9. Gleason J, Ross W, Fossi A, et al. The devastating impact of COVID-19 on individuals with intellectual disabilities in the United States. NEJM Catalyst. March 5, 2021. accessed 29 june 2021.
10. Gleason J, et al, NEJM march 5,2021
11. Ng WH, Tipih T, Makoah NA, et al. Comorbidities in SARS-CoV-2 patients: a systemic review and meta-analysis. mBio 12:e03647-20.
12. Gleason J. et al, NEJM march 5,2021
13. Gleason J, et al, NEJM march 5,2021
14. Ng WH et al, mBio 12:e03647-20.
15. Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581: 465-469
16. Dhont S, Derom E, Van Braeckel E, et al. The pathophysiology of ‘happy’ hipoxemia in COVID-19. Respir Res. 2020;21:198
17. Yu M, Liu Y, Xu D, et al. Prediction of the Development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J Radiol. 2020;21:746-755.
18. Klok FA, Kruip M, van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147
19. Obi A, Barnes G, Napolitano L, et al. Venous thrombosis epidemiology, pathophysiology, and anticoagulante therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9:23-35.
20. Obi A, Pannucci C, Nackashi A, et al. Validation of the Caprini venous thromboembolis risk assessment model in critically ill surgical patients. JAMA Surg. 2015;150:941-948
21. Burkhard-Koren N, Haberecker M, Maccio U, et al. Higher prevalence of Pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from ‘spanish flu’ 1918/1919 in Switzerland to Coronavirus disease 2019. J Pathol Clin Res. 2021; 7:135-143.
22. Leisman D, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19; a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respr Med. 2020; 8: 1233-1244.
23. Mazzoni A, Salvati L, Maggi L, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020; 130:4694-4703
24. Monneret G, Benlyamani I, Gossez M, et al. COVID-19: What type of cytokine storm are we dealing with?. J Med Virol. 2021;93:197198.
25. Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. Macrophage activation- like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15:172.
26. Bao J, Li C,Zhang K, et al. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020; 509:180-194.
27. Soraya G, Ulhaq Z. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated mata-analysis. Med Clin (Barc). 2020; 155:143-151.
28. Yelagandula, R., Bykov, A., Vogt, A. et al. Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq. Nat Commun 12, 3132 (2021).
29. Dinnes J, Deeks JJ, Berhane S, et al. Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database of Systematic Reviews 2021, Issue 3. Art. No.: CD013705. DOI: 10.1002/14651858.CD013705.pub2.
30. Nakano Y, Kurano M, Morita Y, et al. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Nature: Scientific Reports. 2021; 11:2776.
35. Cleverley J, Piper J, Jones M. The role of chest radiography in confirming covid-19 pneumonia. MBJ 2020;370:m2426.
36. Fang Y, Zhang H,Xie J, et al. Sensitivity of chest CT for COVID-19: comparison toRT-PCR. Radiology. 2020
39. Lopes R, Melo de Barros e Silva P, Furtado R, et al. Therapeutic versus prophylactic anticoagulación for patients dmitted to hospital with COVID-19 and an elevated D-dimer concentration (ACTION): an open-label, multicentre, randomized, controlled trial. Lancet 2021; 397:2253-63
41. Recovery Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020. Available at:
44. Liu X, Shaw R, Stuart A, et al. Safety and immunogenicity report from the Com-COV study- a single-blind randomized non-inferiority trial comparing heterologous homologous prime-boost schedules with an Adenoviral vectores and mRNA COVID-19 vaccine. Lancet. 25 June 2021. Preprint.
45. Accessed 21 marzo 2021
46. Accessed 21 marzo 2021
47. accessed 21 marzo 2021
48. accessed 21 marzo 2021
49. Baraniuk C. Covid-19: What do we know about Sputnik V and other Russian vaccines? BMJ 2021;372:n743 (publ 19 Marzo 2021).
50 accessed 5 abril2021
51. Mallapaty S. WHO approval of Chinese China’s CoronaVac vaccine will be crucial to curbing pandemic. Nature. 2021. 595:162.
52. Turner J, O’Halloran J, Kalaidina E, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. Preprint 28 June 2021.
Cómo citar
Herrera D, Gaus D. COVID-19 guía clínica y de manejo: actualización. PFR [Internet]. 30 de julio de 2021 [citado 14 de julio de 2024];6(2). Disponible en:
Artículos de revisión

Artículos más leídos del mismo autor/a

1 2 3 > >>